Pharmacist-Given Long-Acting HIV Injections Study
Part of Infections clinical trials.
This study looks at whether pharmacists can give you your long-acting HIV injections instead of a doctor, making it easier to get your medication. It might help you if you're already stable on these injections and want more convenience.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have HIV and are currently taking Cabotegravir and Rilpivirine injections every 4 or 8 weeks
- You have had at least two doses of these injections
- Your last viral load test was less than 50 copies per milliliter
- You have no known resistance to Cabotegravir or Rilpivirine
- You plan to stay on these injections for the next 48 weeks and not move out of state
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new ultra-long-acting injectable combination of cabotegravir and rilpivirine for people with HIV who already have the virus under control. It aims to see if these shots can keep the virus suppressed with fewer doses.
This study follows adults with well-controlled HIV who are planning to switch to a long-acting HIV medicine given as injections. It may help researchers understand how this approach works for people already stable on current treatment.
This study looks at switching people with HIV from daily or regular oral medicine to long-acting injections (cabotegravir plus rilpivirine). It may help those who are well-controlled on current therapy who prefer injections and can safely take this combination.
This study follows people living with HIV who have undetectable viral loads to see how well a long-acting injectable medication (cabotegravir plus rilpivirine) works in real-world conditions. It may help understand if this injection-based treatment can reliably keep HIV controlled with fewer pills.
This study tests whether two long-acting injectable HIV medications (cabotegravir and rilpivirine) can keep the virus under control in people aged 60 and older. It aims to offer a convenient alternative to daily pills for older adults with HIV.
This trial tests if switching to a long-acting injectable medication can help people with HIV who have trouble keeping their virus suppressed with daily pills. You would receive shots in the buttocks every few months instead of taking pills every day.
Hear when a new HIV I Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.